Clonidine and Roxanol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clonidine (clonidine) and Roxanol (morphine sulfate). Common drug interactions include oedema peripheral among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Clonidine and Roxanol. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

What is Roxanol?

Roxanol has active ingredients of morphine sulfate. eHealthMe is studying from 807 Roxanol users. Check the latest studies of Roxanol.



On Jul, 28, 2026

18 people who take Clonidine and Roxanol together, and have interactions are studied.

Clonidine and Roxanol drug interactions.

What are the common drug interactions of Clonidine and Roxanol, by gender? *:

female:

  1. Oedema peripheral (superficial swelling)
  2. Cellulitis (infection under the skin)
  3. Deformity (disfigurement)
  4. Erythema (redness of the skin)
  5. Fatigue (feeling of tiredness)
  6. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  7. Joint range of motion decreased (disease of joint movement)
  8. Joint stiffness
  9. Mobility decreased (ability to move is reduced)
  10. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

male:

  1. Constipation
  2. Device failure
  3. Neoplasm progression (growth of tumour)
  4. Neurological decompensation (inability of brain to maintain proper function)
  5. Peripheral swelling
  6. T-cell depletion (less supply of t-cell by bone marrow)
  7. Tumour haemorrhage (bleeding from tumour)
  8. Unresponsive to stimuli
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Nerve injury

What are the common drug interactions of Clonidine and Roxanol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Dyspnoea (difficult or laboured respiration)
  2. Peripheral swelling

20-29:

n/a

30-39:

n/a

40-49:

  1. Constipation
  2. Device failure
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Nerve injury
  5. Neuralgia (pain in one or more nerves)
  6. Pain
  7. Rash
  8. Myasthenic syndrome (a group of conditions characterized by muscle weakness (myasthenia) that worsens with physical exertion)
  9. Oedema peripheral (superficial swelling)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

  1. Cellulitis (infection under the skin)
  2. Deformity (disfigurement)
  3. Erythema (redness of the skin)
  4. Fatigue (feeling of tiredness)
  5. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  6. Joint range of motion decreased (disease of joint movement)
  7. Joint stiffness
  8. Mobility decreased (ability to move is reduced)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

60+:

  1. Abdominal pain
  2. Asthenia (weakness)
  3. Weight decreased
  4. Cardiomegaly (increased size of heart than normal)
  5. Chronic kidney disease
  6. Dyspnoea (difficult or laboured respiration)
  7. Nausea (feeling of having an urge to vomit)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Pneumonia
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Pain: 12 people, 66.67%
  2. Stress And Anxiety: 10 people, 55.56%
  3. Nausea (feeling of having an urge to vomit): 10 people, 55.56%
  4. Depression: 10 people, 55.56%
  5. Device Related Infection: 10 people, 55.56%
  6. Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 10 people, 55.56%
  7. Herpes Zoster: 10 people, 55.56%
  8. Itching: 10 people, 55.56%
  9. High Blood Cholesterol: 10 people, 55.56%
  10. Nuclear Magnetic Resonance Imaging Brain: 10 people, 55.56%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and Roxanol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clonidine and Roxanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Roxanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clonidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Roxanol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clonidine and morphine sulfate (the active ingredients of Clonidine and Roxanol, respectively), and Clonidine and Roxanol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: